Steven Jacobsen, Ph.D.
Chief Executive Officer
Steven Jacobsen, Ph.D., was Former Senior Project Director at Translational Neurosciences, Neuroscience iMed, AstraZeneca. Dr. Jacobsen left AstraZeneca, Neuroscience iMed after four years as Senior Director in June 2016. Prior to that he was Vice President, Head of Translational Biology Department at Proteostasis Therapeutics, a neurodegenerative drug development startup, for three years.
He has extensive drug development experience in the pharmaceutical industry having been Senior Research Fellow, Neuroscience Translation at Pfizer Global R&D and Associated Director/Team Leader, Alzheimer’s disease-Modifying Program at Wyeth Research for fifteen years. Prior to that, Dr. Jacobsen was a Senior Scientist in CNS Biology, Lederle Labs, American Cyanamid. In addition, he is a consultant to several biotechnology startup organizations, and adjunct Associate Professor at Ohio State University and New York University School of Medicine.
Dr. Jacobsen obtained his BS in Biology and a MS in Microbiology at Seton Hall University and a Ph.D. in Molecular Genetics and Microbiology from Graduate School of Biomedical Science, New Jersey Medical School.